Hydroxytyrosol Antioxidant Composition for Cellular Damage Reversal

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current dietary and nutritional supplements for maintaining health and addressing oxidative stress-related conditions often lack a scientific foundation, and there is a need for effective compositions that can reverse cellular damage and promote quiescence in at-risk cells to prevent necrosis and promote normal proliferation.

Innovation Solution

Compositions containing hydroxytyrosol, N-acetyl cysteine, and other antioxidants, vitamins, and minerals are administered orally or parenterally to provide a daily dose that reverses cellular damage, promotes quiescence, and inhibits necrosis, thereby improving health and reducing signs of aging and disease.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If conventional dietary supplements are marketed without solid scientific foundation, then marketing flexibility and consumer appeal are improved, but reliability and scientific validity deteriorate

Engineering Contradiction:
Improvemarketing flexibilityVSAvoidscientific validity
Core Design Contradiction:
Adaptability or versatilityVSReliability

Solution Approach 1:

The patent performs preliminary scientific validation by conducting in vitro and in vivo studies to demonstrate the anti-necrotic effects of the composition before marketing. Clinical trials were conducted to prove efficacy in treating conditions like rheumatoid arthritis and hepatitis C, establishing scientific foundation prior to commercialization

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent incorporates feedback mechanisms through clinical monitoring and patient outcome tracking. The composition's effectiveness is continuously evaluated through biomarkers such as reduced oxidative stress levels, improved liver function tests in hepatitis C patients, and decreased joint inflammation in rheumatoid arthritis patients

Inventive Principle:
Principle #23Feedback

2Reliability

If antioxidants are administered to reduce free radical damage, then cellular protection is improved, but dosage precision and potential toxicity risks worsen

Engineering Contradiction:
Improvecellular protectionVSAvoiddosage precision
Core Design Contradiction:
ReliabilityVSManufacturing precision

Solution Approach 1:

The patent optimizes the parameter of antioxidant concentration by formulating a specific composition containing hydroxytyrosol at 2-20 ppm, N-acetyl cysteine at 50-200 ppm, and other antioxidants in defined ratios. This precise parameter control ensures effective cellular protection while minimizing toxicity risks through standardized formulation

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent uses a composite antioxidant formulation combining multiple substances (hydroxytyrosol, N-acetyl cysteine, vitamin C, vitamin E, selenium) that work synergistically. This composite approach distributes the protective effect across multiple components, reducing the burden on any single ingredient and allowing for more precise dosage control of each component

Inventive Principle:
Principle #40Composite materials

3Reliability

If necrosis is allowed to progress to explosive cell rupture, then cellular immune response is activated, but surrounding tissue damage and toxicity increase

Engineering Contradiction:
Improveimmune response activationVSAvoidtissue damage
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent applies preliminary anti-action by administering the antioxidant composition before necrotic cells reach the explosive rupture stage. The composition intervenes during early necrosis (oncosis) when cells are swollen but intact, preventing progression to catastrophic membrane rupture and the release of toxic cellular contents that would damage surrounding tissues

Inventive Principle:
Principle #9Preliminary anti-action

Solution Approach 2:

The patent converts the harmful necrotic process into a beneficial outcome by using oxidative stress-induced necrosis as a target for therapeutic intervention. The antioxidant composition specifically addresses free radical-mediated necrosis, transforming a pathological process into an opportunity for treatment and preventing the harmful consequences of uncontrolled cell death

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The administration of hydroxytyrosol and other components in these compositions effectively reverses cellular damage, improves health, and reduces oxidative stress, leading to improved skin health and reduced symptoms of conditions like rheumatoid arthritis and hepatitis C, with potential cost savings and improved quality of life.

Implementation Method 1

Compositions for and methods of administration of an antioxidant and optionally, other dietary supplements to a subject in need of reducing oxygen free radical-associated disease or condition

Methodology Applied
Scientific EffectFree radical scavenging: Oxidation

Implementation Method 2

Compositions containing hydroxytyrosol, N-acetyl cysteine, and other antioxidants, vitamins, and minerals

Methodology Applied
Scientific EffectGlutathione replenishment:

Implementation Method 3

Controlling necrosis during the early oncosis stage is important. Up to this point, necrosis is a reversible event. The morphology of cells dying by necrosis centers on changes in the cell's permeability

Methodology Applied
Scientific EffectMembrane stabilization:

Data Source

PatentUS9289401B2Nutritional supplements
Publication Date: 2016.03.22 MCCORD DARLENE E
  • US9289401B2 patent drawing
  • US9289401B2 patent drawing

AI summary

A process for improving the health of a subject, the process comprising orally administering a composition comprising hydroxytyrosol to the subject to provide the subject with a daily dose of about 0.1 to about 750 .mu.g hydroxytyrosol per kg of body weight, and a dietary supplement in dosage unit form for oral administration, the dosage unit form comprising a composition containing about 1 microgram to about 50 milligrams hydroxytyrosol or an ester or salt thereof.